Biolaser ApS: Financial statements 2022
CVR: 21333271
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biolaser ApS (CVR 21333271) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 614,407 and a net result of DKK 478,978 compared with DKK 247,670 the year before. That is an increase of 93.5% compared with the year before. Equity in the 2022 report amounted to DKK 1,287,737. The solvency ratio was 80.4%.
- Gross Profit
- DKK 614,407
- Profit/Loss
- DKK 478,978
- Equity
- DKK 1,287,737
- Total Assets
- DKK 1,601,060
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 614 t. | 479 t. | 1.3 mio. | - |
| 2021 | - | 318 t. | 248 t. | 1.1 mio. | 0 |
| 2020 | - | -10 t. | -169 t. | 1 mio. | 1 |
| 2019 | - | 593 t. | 316 t. | 1.2 mio. | 1 |
| 2018 | - | 288 t. | 223 t. | 872 t. | 0 |
Keep an eye on Biolaser ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Biolaser ApS has published its annual report for 2021. Gross profit came to DKK 317,504, and the net result was DKK 247,670.
About Biolaser ApS
Biolaser ApS is a Danish company of the type Anpartsselskab based in Fjerritslev, founded in 1998. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Caitanya Candradasa. The company is owned by Caitanya Candradasa. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -133,181 and a net result of DKK -141,615 compared with DKK 82,521 the year before. Equity in the 2025 report amounted to DKK 685,450.